Task: Answer the multiple-choice question.
Question: Which drug exhibits a -4.754% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a Cc1ccc(Nc2ccc(C(=O)N3CCCC3)cn2)c(C)c1
b O=C(CCCCCNC(=O)N1CCn2c1nc1ccccc12)NCc1ccc(Cl)cc1
Answer: a. Cc1ccc(Nc2ccc(C(=O)N3CCCC3)cn2)c(C)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(Nc2ccc(C(=O)N3CCCC3)cn2)c(C)c1
Cc1ccc(Nc2ccc(C(=O)N3CCCC3)cn2)c(C)c1
[6-(2,4-dimethylanilino)pyridin-3-yl]-pyrrolidin-1-ylmethanone